Current Ratio
Higher than 52% of Healthcare sector peers
Updated 1139h ago
Sector Performance
52th percentileA
2.10x
Sector Median
2.02x
Sector Avg
3.77x
Deep Analysis
A current ratio of 2.10x means Agilent has $2.10 in short-term assets for every $1.00 of short-term liabilities, indicating it can comfortably cover its upcoming obligations.
This is slightly above the healthcare sector median of 2.06x, placing Agilent at the 51st percentile among its peers — essentially in the middle of the pack. The year-over-year change is not available, and the quarter-over-quarter change is also not available, so there is no observable trend from the data provided. Because the current ratio is near the sector median and no trend data exists, the metric suggests neither a material risk nor a clear opportunity on liquidity grounds. This neutral level supports the overall NEUTRAL verdict on Agilent, as it does not point to an advantage or a weakness relative to the sector.
Frequently Asked Questions
What does the Current Ratio tell investors about A?
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
How is the Current Ratio calculated?
Current Ratio is calculated as: Current Assets / Current Liabilities.
How does A's Current Ratio compare to its sector?
A's Current Ratio of 2.10x compares to a Healthcare sector median of 2.02x, placing it in the 52th percentile.
Who are A's closest peers by Current Ratio?
The closest Healthcare peers by Current Ratio include: RARE (2.02x), BSX (1.90x), EXAS (2.23x), TMO (1.53x), ALGN (1.39x).
The Formula
Current Assets / Current Liabilities
Why It Matters
Measures short-term financial health. A ratio above 1.5 is generally healthy; below 1.0 may indicate liquidity stress.
Master A's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full A research report →A
2.10x
Sector Median
2.02x
Sector Avg
3.77x
How A's Current Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.